dWBP4-1
dWBP4-1 (LC-04-118) is a CRBN-dependent molecular glue degrader targeting WBP4. dWBP4-1 binds to the IMiD site of CRBN via its glutarimide ring, induces the formation of the CRBN-WBP4 ternary complex (EC50 = 224 nM), and mediates the rapid degradation of WBP4 through the G-loop dependent ubiquitin-proteasome pathway, a process that can be rescued by MLN4924 (HY-70062), Lenalidomide (HY-A0003) or Bortezomib (HY-10227). dWBP4-1 causes almost no perturbation at the transcriptome and alternative splicing levels, exhibits no obvious cytotoxicity, and produces no hook effect. dWBP4-1 can be used for the construction of chemical genetic protein degradation platforms and research related to acute T-lymphoblastic leukemia.
For research use only. We do not sell to patients.
- Formula: C29H28N4O4
- Molecular Weight:496.56
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
dWBP4-1 (6 h) potently induces degradation of HiBiT-tagged WBP4 in MOLT-4 cells, with a DC50 of 3.4 nM[1].
dWBP4-1 (100 nM; 0.5-6 h) rapidly and dose-dependently induces the degradation of endogenous WBP4 in MOLT-4 cells, and this degradation effect depends on CRBN and the ubiquitin-proteasome pathway[1].
dWBP4-1 (1 μM; treatment for 1-24 h with 1 h pretreatment of Cycloheximide (HY-12320)) accelerates the degradation kinetics of endogenous WBP4 in HEK293T cells, and reduces the protein half-life when combined with Cycloheximide[1].
The CRBN-dependent degradation of endogenous WBP4 mediated by dWBP4-1 (1-1000 nM; 6 h) in HEK293T cells is strictly dependent on CRBN[1].
dWBP4-1 (1 μM; 6 h) exhibits excellent whole-proteome selectivity in MOLT-4 cells, as it specifically degrades WBP4 at a concentration of 1 μM without altering the levels of other IMiD targets or spliceosome proteins[1].
dWBP4-1 binds directly and specifically to CRBN with an IC50 of 378 nM[1].
dWBP4-1 induces the formation of the CRBN-dWBP4-1-WBP4 ternary complex, with an EC50 value of 224 nM[1].
Degradation of WBP4 induced by dWBP4-1 (6 h) in MOLT-4 cells depends on the G-loop region of the WW1 domain of WBP4, as the WBP4G146N mutation abolishes efficient degradation[1].
dWBP4-1 (1-10 μM) induces degradation of the WBP4 truncation-EGFP fusion protein in HEK293T cells, and a 41-amino-acid wTAG sequence serves as the minimal functional degron[1].
dWBP4-1 (0.17-10000 nM; 1-24 h) induces rapid, potent and monotonic degradation of N-terminal and C-terminal wTAG-fused BRD4-BD1 and PLK1 in HEK293T cells, with DC50 values ranging from 1.4 nM to 31 nM, and no hook effect is observed[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:wild-type MOLT-4 cells
-
Concentration:100 nM (degradation time course); 1, 10, 100 and 1000 nM (6 h dose-response); 100 nM (rescue experiments)
-
Incubation Time:0.5, 1, 1.5, 2, 2.5 h (100 nM); 6 h (1-1000 nM); 2 h (100 nM, with 1 h pretreatment of rescue agents)
-
Result:Induced rapid WBP4 degradation detectable as early as 30 min post-treatment at 100 nM.
Induced dose-dependent degradation across 1-1000 nM after 6 h.
Pretreatment with 1 μM NEDD8-activating enzyme inhibitor, 10 μM cereblon modulatory agent, or 0.4 μM proteasome inhibitor completely rescued dWBP4-1-induced WBP4 degradation.
-
Cell Line:wild-type HEK293T cells
-
Concentration:1 μM
-
Incubation Time:1, 2, 4, 8, 24 h (with 1 h Cycloheximide (HY-12320) pretreatment)
-
Result:Significantly accelerated the rate of WBP4 protein loss compared to CHX alone, with WBP4 levels becoming undetectable by 8 h post-treatment.
-
Cell Line:wild-type and CRBN-/- HEK293T cells
-
Concentration:1, 10, 100 and 1000 nM
-
Incubation Time:6 h
-
Result:Induced dose-dependent WBP4 degradation in wild-type HEK293T cells, but this effect was completely abolished in CRBN-/- HEK293T cells.
-
Cell Line:stable HEK293T cell lines expressing wTAG-fused oncoproteins (N-terminal wTAG-BRD4-BD1, N-terminal wTAG-PLK1, C-terminal BRD4-BD1-wTAG, C-terminal PLK1-wTAG)
-
Concentration:1 μM (time course); 0.17, 0.5, 1.5, 4.6, 13.7, 14, 123, 370, 1111, 3333 and 10000 nM (dose-response: N-terminal fusions, C-terminal fusions)
-
Incubation Time:1, 3, 6, 12, 24 h (1 μM); 3 h (N-terminal fusions dose-response); 6 h (C-terminal fusions dose-response)
-
Result:Triggered rapid degradation of all wTAG-fused proteins, with near-complete clearance within hours.
N-terminal wTAG-BRD4-BD1 had a DC50 of 31 nM and Dₘₐₓ of 92%; N-terminal wTAG-PLK1 had a DC50 of 22 nM and Dₘₐₓ of 80%.
C-terminal BRD4-BD1-wTAG had a DC50 of 4.7 nM and Dₘₐₓ of 96%; C-terminal PLK1-wTAG had a DC50 of 1.4 nM and Dₘₐₓ of 84%.
All constructs showed monotonic dose-response profiles without a hook effect up to 10 μM.
Chemical Information
-
Molecular Weight 496.56
-
Formula C29H28N4O4
-
SMILES
O=C1[C@@H](N2C(C(C=CC(C(N3CCN(CC3)CC4=C5C=CC=CC5=CC=C4)=O)=C6)=C6C2)=O)CCC(N1)=O
-
Synonyms
LC-04-118
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)